Jacob Gottlieb was recently featured in the Affiliate Dork article written by Brandon Ferguson titled “Jacob Gottlieb’s Altium Capital: Disrupting the Healthcare Investment Sector One Venture at a Time.” The article reveals how investing in the healthcare industry is about to change.
Jacob Gottlieb is one of the most successful financial entrepreneurs who focuses on healthcare investing. He has recently added another company to his investment fund. Altium Capital is based in New York City and works to invest in companies that will grow in the healthcare industry. He particularly hopes to invest in companies that want to provide medical advances in treatment.
Altium recently chose Oramed Pharmaceuticals to invest in as well as Amarin Corporations and Oragenics. The first investment for the company was a bit more than a 5% stake in Oramed Pharmaceuticals. Oramed creates oral treatment alternatives for those who are receiving injectable drugs. They have released and tested a successful ingestible capsule that releases insulin. They are proud of their management team that has experience in both pharmaceuticals and business. They are also continuously supported by scientific experts.
Amarin is a growing pharmaceutical company that is based in Dublin, Ireland. However, they also have offices stateside in Bedminster, New Jersey. The company is hoping to create better drugs to improve cardiovascular and heart health. The company focuses on the scientific expertise of lipids and possible benefits of polyunsaturated acids. They had their first FDA-approved drug released in 2012. The prescription grade omega-3 fatty acid is called Vascepa.
Oragenics was created by two doctors who wanted to understand the benefits of Replacement Therapy. The company has become a leader in the use of different antibiotics to prevent or treat infectious diseases. They also work on replacing harmful bacteria with healthy bacteria to balance out the body. They have also developed biotherapeutics for a variety of conditions of the oral cavity.